title: Efalizumab-induced bullous pemphigoid.
authors.affiliation: Department of Dermatology, Hôpital Henri Mondor, Université Paris, Créteil, France. Electronic address: tu-anh.duong@hmn.aphp.fr.
authors.forename: Tu Anh
authors.initials: TA
authors.lastname: Duong
authors.affiliation: Department of Dermatology, Hôpital Henri Mondor, Université Paris, Créteil, France.
authors.forename: Valérie
authors.initials: V
authors.lastname: Buffard
authors.affiliation: Department of Immunology, Hôpital Henri Mondor, Université Paris, Créteil, France.
authors.forename: Chantal
authors.initials: C
authors.lastname: André
authors.affiliation: Department of Pathology, Hôpital Henri Mondor, Université Paris, Créteil, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Ortonne
authors.affiliation: Department of Dermatology, Hôpital Henri Mondor, Université Paris, Créteil, France.
authors.forename: Jean
authors.initials: J
authors.lastname: Revuz
authors.affiliation: Department of Dermatology, Hôpital Henri Mondor, Université Paris, Créteil, France.
authors.forename: Martine
authors.initials: M
authors.lastname: Bagot
authors.affiliation: Department of Dermatology, Hôpital Henri Mondor, Université Paris, Créteil, France.
authors.forename: Jean-Claude
authors.initials: JC
authors.lastname: Roujeau
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens / Q000008:administration & dosage / Q000009:adverse effects*; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000139:chemically induced* / Q000188:drug therapy; D011565:Psoriasis / Q000188:drug therapy
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; D005938:Glucocorticoids; C472181:efalizumab